PHARMARON (03759) Schedules 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express03-16

Pharmaron Beijing Co., Ltd. (stock code: 03759) has announced that its board of directors will convene on 30 March 2026. The agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. • Considering a recommendation for the payment of a final dividend, if any.

Board composition as of the announcement date (16 March 2026) is as follows: – Executive Directors: Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang, Ms. Zheng Bei – Employee Representative Director: Mr. Li Shing Chung Gilbert – Non-executive Directors: Mr. Li Jiaqing, Ms. Wan Xuan – Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Mr. Yu Jian

The notice was issued in Beijing and signed by Chairman Dr. Lou Boliang on behalf of the Board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154681506?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154681506","market":"us","top_or_hot":-1,"title":"PHARMARON (03759) Schedules 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (stock code: 03759) has announced that its board of directors will convene on 30 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for the payment of a final dividend, if any.</p>\n<p>Board composition as of the announcement date (16 March 2026) is as follows:  \n– Executive Directors: Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n– Employee Representative Director: Mr. Li Shing Chung Gilbert  \n– Non-executive Directors: Mr. Li Jiaqing, Ms. Wan Xuan  \n– Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Mr. Yu Jian</p>\n<p>The notice was issued in Beijing and signed by Chairman Dr. Lou Boliang on behalf of the Board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PHARMARON (03759) Schedules 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPHARMARON (03759) Schedules 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (stock code: 03759) has announced that its board of directors will convene on 30 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for the payment of a final dividend, if any.</p>\n<p>Board composition as of the announcement date (16 March 2026) is as follows:  \n– Executive Directors: Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n– Employee Representative Director: Mr. Li Shing Chung Gilbert  \n– Non-executive Directors: Mr. Li Jiaqing, Ms. Wan Xuan  \n– Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Mr. Yu Jian</p>\n<p>The notice was issued in Beijing and signed by Chairman Dr. Lou Boliang on behalf of the Board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1154681506","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154681506","pubTimestamp":1773650509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (stock code: 03759) has announced that its board of directors will convene on 30 March 2026. The agenda includes: • Reviewing and approving the consolidated annual results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成(03759)定于2026年3月30日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (stock code: 03759) has announced that its board of directors will convene on 30 March 2026. The agenda includes:\n• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for the payment of a final dividend, if any.\nBoard composition as of the announcement date (16 March 2026) is as follows:  \n– Executive Directors: Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n– Employee Representative Director: Mr. Li Shing Chung Gilbert  \n– Non-executive Directors: Mr. Li Jiaqing, Ms. Wan Xuan  \n– Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Mr. Yu Jian\nThe notice was issued in Beijing and signed by Chairman Dr. Lou Boliang on behalf of the Board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154681506","isCrawlerRequest":true}